Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies
暂无分享，去创建一个
J. Carles | E. Sokol | E. Antonarakis | A. Vivancos | A. Zurita | J. Mateo | G. Oxnard | A. Schrock | R. Huang | R. Graf | D. Jin | I. Casanova-Salas | Gerald Li | K. Raskina | G. Villacampa | J. Ross | J. Ross | Richard S. P. Huang